Skip to main content
Fig. 8 | BMC Infectious Diseases

Fig. 8

From: Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

Fig. 8

Composition of intestinal fungal microbiota. A Proportion of the different classes in each sample. B-F Relative abundance of top 5 classes of gut fungus among three groups. B-E One-way ANOVA and Tukey’s multiple comparisons test were used, and data were shown as mean ± SD; F Kruskal-Wallis and Dunn’s multiple comparisons test were used, and data were shown as median and IQR. *P < 0.05; **P < 0.01

Back to article page